| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |